|
V.TLT
|
Thanks, Robertshaw....agree'd
|
|
V.TLT
|
ScienceFirst....Thanks....Your timeline is clear and reasonable. Quick...
|
|
V.TLT
|
Thank you, 99942apophis....from one gentleman to another...I,too. anticipate...
|
|
V.TLT
|
Agree'd in full, Kingpin68....If the FDA provided guidance that included...
|
|
V.TLT
|
The recent corporate update kicked me a bit....the company had forecasted BTD...
|
|
V.TLT
|
My sense of todays downturn seems to be fueled by the recent corporate update...
|
|
V.TLT
|
Agree'd...My guess is Feb. 28 after hours...or early March 1.
|
|
V.TLT
|
Agree'd....My continued interest and investment in Theralase over these 8...
|
|
V.TLT
|
Wishing all contributors to this board a blessed 2022. As I enter my 8th...
|
|
V.TLT
|
What, in God's name, could Dr, Mc Farland/ Team have discovered that...
|
|
V.TLT
|
Inexplicable!...Wow!!!
|
|
V.TLT
|
You've been a community member since November, 21, 2021. Thanks for the...
|
|
V.TLT
|
My Word!...Well done!!...Let us hope that your calculations are the beginning...
|
|
V.TLT
|
Perfectly articulated...thank you.
|
|
V.TLT
|
From the UChicagoMedicine Trial Site: This is a Phase II, open label, single...
|
|
V.TLT
|
Yes, Enriquesuave, the data and prospects for the company have continued to...
|
|
V.TLT
|
Perhaps the company’s equity price is indicative of a dilemma that long term...
|
|
V.TLT
|
It remains, for me, a testament to the brilliance of this company’s clinical...
|
|
V.TLT
|
Could there be a potential buy out of the company’s clinical division? Thus...
|
|
V.TLT
|
Thanks, StevenBirch....The longer this wait extends the less I am inclined to...
|